2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Kitay B, Murphy E, Macaluso M, Corlett P, Hershenberg R, Joormann J, Martinez-Kaigi V, Nikayin S, Rhee T, Sanacora G, Shelton R, Thase M, Wilkinson S. Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research 2023, 330: 115585. PMID: 37935086, DOI: 10.1016/j.psychres.2023.115585.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMajor depressionSuicidal ideationRelapse preventionBehavioral therapyStudy protocolHigh riskClinical trial study protocolLong-term treatment approachKey secondary outcomesTrial study protocolHigh relapse rateHigh-risk populationSignificant suicidal ideationHospital dischargeSecondary outcomesPrimary outcomeRelapse rateFeasibility trialEsketamineTreatment approachesPatientsSuicide attemptsTherapySupplemental indicationsUtility of Wrist-Wearable Data for Assessing Pain, Sleep, and Anxiety Outcomes After Traumatic Stress Exposure
Straus L, An X, Ji Y, McLean S, Neylan T, Cakmak A, Richards A, Clifford G, Liu M, Zeng D, House S, Beaudoin F, Stevens J, Linnstaedt S, Germine L, Bollen K, Rauch S, Haran J, Storrow A, Lewandowski C, Musey P, Hendry P, Sheikh S, Jones C, Punches B, Kurz M, Swor R, Hudak L, Seamon M, Datner E, Chang A, Pearson C, Peak D, Merchant R, Domeier R, Rathlev N, O’Neil B, Sergot P, Sanchez L, Bruce S, Miller M, Pietrzak R, Joormann J, Barch D, Pizzagalli D, Sheridan J, Harte S, Elliott J, Kessler R, Ressler K, Koenen K. Utility of Wrist-Wearable Data for Assessing Pain, Sleep, and Anxiety Outcomes After Traumatic Stress Exposure. JAMA Psychiatry 2023, 80: 220-229. PMID: 36630119, PMCID: PMC9857758, DOI: 10.1001/jamapsychiatry.2022.4533.Peer-Reviewed Original ResearchConceptsTraumatic stress exposureAdverse posttraumatic neuropsychiatric sequelaeEmergency departmentStress exposureNeuropsychiatric sequelaeGreater pain severityPain severityDerivation cohortNeuropsychiatric symptomsMean ageStudy criteriaSerial assessmentSleep disruptionMAIN OUTCOMEHigh incidenceUseful biomarkerBaseline assessmentPainSymptom severityDiverse cohortInformed consentPatientsSymptom domainsSleepDisadvantaged populations
2022
Development of a model to predict antidepressant treatment response for depression among Veterans
Puac-Polanco V, Ziobrowski H, Ross E, Liu H, Turner B, Cui R, Leung L, Bossarte R, Bryant C, Joormann J, Nierenberg A, Oslin D, Pigeon W, Post E, Zainal N, Zaslavsky A, Zubizarreta J, Luedtke A, Kennedy C, Cipriani A, Furukawa T, Kessler R. Development of a model to predict antidepressant treatment response for depression among Veterans. Psychological Medicine 2022, 53: 5001-5011. PMID: 37650342, PMCID: PMC10519376, DOI: 10.1017/s0033291722001982.Peer-Reviewed Original ResearchConceptsMajor depressive disorderVeterans Health AdministrationTreatment responseAntidepressant medicationADM treatmentDepression Symptomatology-Self ReportUS Veterans Health AdministrationBaseline self-reported dataAntidepressant treatment responseSheehan Disability ScaleBaseline symptom severityBeginning of treatmentVHA patientsQuick InventoryDisability ScaleDepressive disorderTreatment characteristicsSelf-report assessmentsTreatment selectionAlternative treatmentHealth AdministrationPatientsSymptom severityROC curveSelf-reported data
2021
Development and Validation of a Model to Predict Posttraumatic Stress Disorder and Major Depression After a Motor Vehicle Collision
Ziobrowski HN, Kennedy CJ, Ustun B, House SL, Beaudoin FL, An X, Zeng D, Bollen KA, Petukhova M, Sampson NA, Puac-Polanco V, Lee S, Koenen KC, Ressler KJ, McLean SA, Kessler RC, Stevens J, Neylan T, Clifford G, Jovanovic T, Linnstaedt S, Germine L, Rauch S, Haran J, Storrow A, Lewandowski C, Musey P, Hendry P, Sheikh S, Jones C, Punches B, Lyons M, Murty V, McGrath M, Pascual J, Seamon M, Datner E, Chang A, Pearson C, Peak D, Jambaulikar G, Merchant R, Domeier R, Rathlev N, O’Neil B, Sergot P, Sanchez L, Bruce S, Pietrzak R, Joormann J, Barch D, Pizzagalli D, Sheridan J, Harte S, Elliott J, van Rooij S. Development and Validation of a Model to Predict Posttraumatic Stress Disorder and Major Depression After a Motor Vehicle Collision. JAMA Psychiatry 2021, 78: 1228-1237. PMID: 34468741, PMCID: PMC8411364, DOI: 10.1001/jamapsychiatry.2021.2427.Peer-Reviewed Original ResearchMeSH KeywordsAccidents, TrafficAdolescentAdultAgedDepressive Disorder, MajorEmergency Service, HospitalFemaleHumansLongitudinal StudiesMachine LearningMaleMiddle AgedModels, TheoreticalPrognosisPsychological TraumaPsychometricsRisk AssessmentStress Disorders, Post-TraumaticWounds and InjuriesYoung AdultConceptsMajor depressive episodePosttraumatic stress disorderEmergency departmentUrban emergency departmentMotor vehicle collisionsSurvey 2 weeksDepressive episodeED assessmentMAIN OUTCOMEHigh riskPatientsPreventive interventionsED reportsPTSD ChecklistStress disorderSubstantial proportionLongitudinal studyVehicle collisionsDSM-5Prognostic reportsTraumatic eventsWeeksMonthsTraumatic experiencesReport
2005
The Impact of Comorbidity of Depression on the Course of Anxiety Treatments
Joormann J, Kosfelder J, Schulte D. The Impact of Comorbidity of Depression on the Course of Anxiety Treatments. Cognitive Therapy And Research 2005, 29: 569-591. DOI: 10.1007/s10608-005-3340-5.Peer-Reviewed Original ResearchCognitive-behavioral treatmentSocial anxiety disorderPanic disorderComorbid depressionAnxiety disorder patientsDepression scoresGrowth curve modelsCourse of anxietyIndividual differencesAnxiety treatmentAnxiety disordersComorbid disordersNoncomorbid patientsAnxiety scoresDisorder patientsDepressionImpact of comorbiditiesDisordersMajor depressionComorbid conditionsComparable improvementPatientsScoresAnxietyDetrimental effects